Skip to main content
. 2022 Oct 3;12(10):1417. doi: 10.3390/biom12101417

Figure 3.

Figure 3

(A) Percentage and number of pathogenic or likely pathogenic variants collectively identified in the study cohort and (B) divided by main and uncommon genes according to clinical phenotype.